165 related articles for article (PubMed ID: 1081146)
1. Considerations of some current concepts in cancer research.
Möller G; Möller E
J Natl Cancer Inst; 1975 Oct; 55(4):755-9. PubMed ID: 1081146
[No Abstract] [Full Text] [Related]
2. Tumor progression and homeostasis.
Prehn RT
Adv Cancer Res; 1976; 23():203-36. PubMed ID: 775933
[No Abstract] [Full Text] [Related]
3. [Immunosuppression mechanism affecting the development of neoplasms].
Rupniewska ZM; Kurowska M
Pol Tyg Lek; 1980 Mar; 35(12):455-7. PubMed ID: 6966796
[No Abstract] [Full Text] [Related]
4. The role of the immune response in oncogenesis.
Jeejeebhoy HF
In Vitro; 1975; 11(3):166-72. PubMed ID: 1165104
[No Abstract] [Full Text] [Related]
5. Genetic alterations in tumor cells resulting in their escape from the immune response.
Hyman R
Cancer Chemother Rep; 1974; 58(4):431-9. PubMed ID: 4136747
[No Abstract] [Full Text] [Related]
6. Current aspects of tumor immunology. Preface and introduction.
Weiss DW
Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649
[No Abstract] [Full Text] [Related]
7. Immunosurveillance, regeneration and oncogenesis.
Prehn RT
Prog Exp Tumor Res; 1971; 14():1-24. PubMed ID: 4944395
[No Abstract] [Full Text] [Related]
8. An overview of cancer immunology.
Ritts RE; Neel HB
Mayo Clin Proc; 1974 Feb; 49(2):118-31. PubMed ID: 4591299
[No Abstract] [Full Text] [Related]
9. Immunologic interreactions in neoplastic diseases. A brief review.
Kushnick T
Clin Pediatr (Phila); 1971 Jul; 10(7):372-6. PubMed ID: 4933466
[No Abstract] [Full Text] [Related]
10. Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: implications for H-antigen diversity.
Doherty PC; Blanden RV; Zinkernagel RM
Transplant Rev; 1976; 29():89-124. PubMed ID: 58463
[No Abstract] [Full Text] [Related]
11. The nude mouse vs. the hypothesis of immunological surveillance.
Rygaard J; Povlsen CO
Transplant Rev; 1976; 28():43-61. PubMed ID: 1251462
[No Abstract] [Full Text] [Related]
12. [Etiology of cancer].
Pérez Tamayo R
Prensa Med Mex; 1974 Mar; 39(3-4):189-201. PubMed ID: 4409498
[No Abstract] [Full Text] [Related]
13. Relevance of virus-induced immunodepression to oncogenesis.
Bendinelli M
G Batteriol Virol Immunol; 1974; 67(7-12):173-9. PubMed ID: 4478766
[No Abstract] [Full Text] [Related]
14. [Regulatory problems in tumor immunology].
Pasternak G
Allerg Immunol (Leipz); 1973; 19(2-4):307-19. PubMed ID: 4281633
[No Abstract] [Full Text] [Related]
15. [Mechanisms of tumor induction in light of a general theory of oncogenesis].
Mekler LB
Usp Sovrem Biol; 1978; 85(1):134-51. PubMed ID: 654486
[No Abstract] [Full Text] [Related]
16. Malignancy as a complication of immunosuppressive therapy.
Leibowitz S; Schwartz RS
Adv Intern Med; 1971; 17():95-123. PubMed ID: 4145004
[No Abstract] [Full Text] [Related]
17. [Immunological supervision and carcinogenesis].
Gorelik LS
Usp Sovrem Biol; 1975; 80(2):270-86. PubMed ID: 55009
[No Abstract] [Full Text] [Related]
18. [Immunosuppression in cancer--depression of immunological function in the host from initiation to neoplasm-bearing state].
Kitagawa M
Nihon Rinsho; 1970 Jul; 28(7):1863-8. PubMed ID: 4918413
[No Abstract] [Full Text] [Related]
19. Role of H-2 antigens in the cytolysis of Oncornavirus induced tumour cells by syngeneic T lymphocytes [proceedings].
Gomard E; Duprez V; Henin Y; Levy JP
Folia Biol (Praha); 1976; 22(6):387-8. PubMed ID: 1087248
[No Abstract] [Full Text] [Related]
20. Immunosuppression and neoplasia. II. Is deficient immunesurveillance the only mechanism by which immunosuppression promotes neoplasia? A speculative review.
Gleichmann E; Gleichmann H
Klin Wochenschr; 1973 Mar; 51(6):260-5 concl. PubMed ID: 4144595
[No Abstract] [Full Text] [Related]
[Next] [New Search]
